Molecular aspects of circadian pharmacology and relevance for cancer chronotherapy
The circadian timing system (CTS) controls various biological functions in mammals
including xenobiotic metabolism and detoxification, immune functions, cell cycle events …
including xenobiotic metabolism and detoxification, immune functions, cell cycle events …
Critical roles of EGFR family members in breast cancer and breast cancer stem cells: targets for therapy
LS Steelman, T Fitzgerald… - Current …, 2016 - ingentaconnect.com
The roles of the epidermal growth factor receptor (EGFR) signaling pathway in various
cancers including breast, bladder, brain, colorectal, esophageal, gastric, head and neck …
cancers including breast, bladder, brain, colorectal, esophageal, gastric, head and neck …
Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II
T Takayanagi, T Kawai, SJ Forrester, T Obama… - …, 2015 - Am Heart Assoc
The mechanisms by which angiotensin II (AngII) elevates blood pressure and enhances end-
organ damage seem to be distinct. However, the signal transduction cascade by which AngII …
organ damage seem to be distinct. However, the signal transduction cascade by which AngII …
Protein kinase Cα mediates erlotinib resistance in lung cancer cells
MB Abera, MG Kazanietz - Molecular pharmacology, 2015 - ASPET
Overexpression and mutational activation of the epidermal growth factor receptor (EGFR)
plays an important role in the pathogenesis of non–small cell lung cancer (NSCLC). EGFR …
plays an important role in the pathogenesis of non–small cell lung cancer (NSCLC). EGFR …
Hepatocyte-specific Smad4 deficiency alleviates liver fibrosis via the p38/p65 pathway
M Wei, X Yan, X Xin, H Chen, L Hou… - International Journal of …, 2022 - mdpi.com
Liver fibrosis is a wound-healing response caused by the abnormal accumulation of
extracellular matrix, which is produced by activated hepatic stellate cells (HSCs). Most …
extracellular matrix, which is produced by activated hepatic stellate cells (HSCs). Most …
PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation
Mutational activation of the epidermal growth factor receptor (EGFR) is a major player in the
pathogenesis of non-small cell lung cancer (NSCLC). NSCLC patients with constitutively …
pathogenesis of non-small cell lung cancer (NSCLC). NSCLC patients with constitutively …
[HTML][HTML] Pharmacological drug screening to inhibit uveal melanoma metastatic cells either via EGF-R, MAPK, mTOR or PI3K
S Kassumeh, S Arrow, A Kafka, N Luft… - International Journal …, 2022 - ncbi.nlm.nih.gov
AIM To screen five potential pharmacological substances specifically targeting EGF-R,
MAPK, mTOR, or PI3K for their antiproliferative effects, possible impact on cell viability, as …
MAPK, mTOR, or PI3K for their antiproliferative effects, possible impact on cell viability, as …
Epidermal growth factor receptor tyrosine kinase inhibitor erlotinib induces dry skin via decreased in aquaporin-3 expression
N Ikarashi, M Kaneko, T Watanabe, R Kon, M Yoshino… - Biomolecules, 2020 - mdpi.com
An adverse reaction of dry skin occurs frequently during treatment with anticancer epidermal
growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). In this study, we conducted …
growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). In this study, we conducted …
[PDF][PDF] Breve evolución histórica del cáncer
A Graña - Καρκίνος Carcinos, 2015 - oncosalud.pe
Breve evolución histórica del cáncer Page 32 Breve evolución histórica del cáncer Brief
historical evolution of cancer Se revisa la historia del cáncer desde tiempos remotos en la …
historical evolution of cancer Se revisa la historia del cáncer desde tiempos remotos en la …
Chronopharmacodynamics and mechanisms of antitumor effect induced by erlotinib in xenograft-bearing nude mice
P Lin, F An, X Xu, L Zhao, L Liu, N Liu, P Wang… - Biochemical and …, 2015 - Elsevier
Receptor tyrosine kinases, mediators of a variety of critical cellular functions, contribute to
tumor progression and metastasis. The epidermal growth factor receptor (EGFR), a member …
tumor progression and metastasis. The epidermal growth factor receptor (EGFR), a member …